Pan-PIM Kinase Inhibitors Enhance Lenalidomide’s Anti-myeloma Activity Via Cereblon-IKZF1/3 Cascade

Multiple myeloma remains an incurable disease, and continued efforts are required to develop novel agents and novel drug combinations with more effective anti-myeloma activity. Here, we show that the pan-PIM kinase inhibitors SGI1776 and CX6258 exhibit significant anti-myeloma activity and that comb...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Lett
Asıl Yazarlar: Zheng, Jing, Sha, Yonggang, Roof, Logan, Foreman, Oded, Lazarchick, John, Venkta, Jagadish Kummetha, Kozlowski, Cleopatra, Gasparetto, Cristina, Chao, Nelson, Ebens, Allen, Hu, Jianda, Kang, Yubin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290736/
https://ncbi.nlm.nih.gov/pubmed/30312729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.10.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller